Charisse K. Green

FDA investigator

Appears on 5 documents from 2005 to 2015, mostly at sites in New York. Most often cites hazard analysis and Hazard Analysis Critical Control Point (HACCP) plan (21 CFR 123.6).

5
Documents on file
6.2
Observations per 483
2005
First seen
2015
Most recent

What they cite most

From 31 observations

Activity by year

2005: 1, 2012: 1, 2014: 1, 2015: 2

Where

New York 4 · New Hampshire 1

Is Charisse K. Green coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Gemini Pharmaceuticals, Inc. dba Plus PharmaJun 30, 2015 · Commack, New York
483 Allegiant HealthJun 2, 2015 · Deer Park, New York
483 Kings Park Slope, Inc.Mar 14, 2014 · Brooklyn, New York
483 Boston Analytical, Inc.Nov 9, 2012 · Salem, New Hampshire
Amended 483 Haifa Smoked Fish, Inc.Oct 7, 2005 · Jamaica, New York

About this profile

What does Charisse K. Green inspect?

Charisse K. Green appears on 5 documents on file covering 5 sites, mostly in New York.

What do they cite most often?

21 CFR 123.6 (hazard analysis and Hazard Analysis Critical Control Point (HACCP) plan), followed by 21 CFR 211.160 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Charisse K. Green is dated Jun 30, 2015.